各种靶向药和化疗药物的说明书

老马兄很好，很好

健择（吉西他滨）+顺铂+阿瓦斯汀
+ E6 i) t8 ~' ^6 H% ` Gemzar +Cisplatin + Avastin
http://annonc.oxfordjournals.org/content/21/9/1804.full
" z! n9 D0 a$ _Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
* M3 M! O# L0 m1 sPatients and methods: Patients (n = 1043) received cisplatin 80 mg/m2 and gemcitabine 1250 mg/m2 for up to six cycles plus bevacizumab 7.5 mg/kg (n = 345), bevacizumab 15 mg/kg (n = 351) or placebo (n = 347) every 3 weeks until progression. Primary end point was progression-free survival (PFS); OS was a secondary end point.
3 z! u9 _3 ]0 r7 @$ z$ ~7 k7 JResults: Significant PFS prolongation with bevacizumab compared with placebo was maintained with longer follow-up {hazard ratio (HR) [95% confidence interval (CI)] 0.75 (0.64–0.87), P = 0.0003 and 0.85 (0.73–1.00), P = 0.0456} for the 7.5 and 15 mg/kg groups, respectively. Median OS was >13 months in all treatment groups; nevertheless, OS was not significantly increased with bevacizumab [HR (95% CI) 0.93 (0.78–1.11), P = 0.420 and 1.03 (0.86–1.23), P = 0.761] for the 7.5 and 15 mg/kg groups, respectively, versus placebo. Most patients (62%) received multiple lines of poststudy treatment. Updated safety results are consistent with those previously reported.
Cisplatin Gemzar Avastin.PDF (329.84 KB, 下载次数: 534)

2013-3-13 13:39 上传

点击文件名下载附件

2 d# R* @! n+ K华为网盘附件：
【华为网盘】ava.JPG
& K0 Z- y( N" v

这个很实用，很好
6 s5 R  q- U6 l3 J: r谢谢

知识很全,谢谢老马提供

论坛里有用信息真多，努力学习中…
" v  B8 }) ^/ w; Z# A6 [
! {# H  P7 L& a/ g9 \6 d谢谢老马，谢谢大家！

有没有每个肿瘤的用药组合推荐啊？

收藏了谢谢老马。

此帖必火

老马整理的太好了~~感谢啊！